| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |